Tallaght Hospital admits losing test results of up to 100 patients

May 15, 2016

Tallaght Hospital says it has lost the results of almost 100 patients who were tested for stomach bacteria that can cause ulcers and stomach cancer. The results of 97 patients who underwent urea breath testing “can no longer be located on the computer system,” the hospital said in response to inquiries from The Irish Times. Urea breath testing is a non-invasive way of diagnosing infection with Helicobacter pylori, bacteria that can grow in the lining of the stomach, and are an important cause of stomach cancer and some types of lymphoma.

Spotlight

As an industry, healthcare is not always quick to embrace emerging technologies. When the cost of failure amounts to much more than money, patient safety, trust, and well-being must come first. However, healthcare technology is now poised for explosive growth as organizations seeking to enable better population health management and embrace preventative care take action to support new apps and devices on their own networks and platforms. Already, technology trends that drive improved care experiences, empower individuals and support smart aftercare are making their mark. Here, we explore several ways this is playing out across the industry.

Spotlight

As an industry, healthcare is not always quick to embrace emerging technologies. When the cost of failure amounts to much more than money, patient safety, trust, and well-being must come first. However, healthcare technology is now poised for explosive growth as organizations seeking to enable better population health management and embrace preventative care take action to support new apps and devices on their own networks and platforms. Already, technology trends that drive improved care experiences, empower individuals and support smart aftercare are making their mark. Here, we explore several ways this is playing out across the industry.

Related News

DIGITAL HEALTHCARE

Softhread Announces Successful Completion of a Pilot with the MDEpiNet Coordinating Center at Weill Cornell Medicine

MDEpiNet | December 28, 2021

We are pleased to announce the results of a successful collaboration between MDEpinet-HIVE and Softhread Inc. on a demonstration pilot to highlight the technical feasibility of integrating the Chios™ blockchain platform with the High-performance Integrated Virtual Environment (HIVE), which was conducted in partnership with HIVE system owners. The ecosystem has been built using High-performance Integrated Virtual Environment (HIVE) as provided by DNAHIVE and Blockchain data provenance and smart contract-driven permissioning system as provided by Softhread. The pilot was completed and demoed to the 2021 Temporomandibular Joint Coordinated Registry Network to showcase the first implementation of a patient-driven data registry ecosystem for Temporomandibular Joint Disorders. "We are thrilled to be part of the MDEpiNet technology vision plan and to work with Softhread technology team on such foundational set of projects that will have a major impact on the way data-driven healthcare is conducted in the future. There is simply no other technology alternative to conducting complex analytics with such a sensitive dataset." DNAHIVE's Chief Scientist Dr. Vahan Simonyan "We are extremely pleased to have demonstrated several of the core capabilities of our Chios™ platform during this pilot, such as pre-built, privacy-preserving smart contracts, advanced access control overlays, support for the publish/subscribe messaging pattern, and integration with off-chain, confidentiality-preserving machine learning models," said Dr. Yelena Yesha, Co-Founder, and Chairwoman of Softhread. This project is only the first step in highlighting the broader opportunities in leveraging and deploying the capabilities of our technology solutions that would address major pain points in the healthcare and life-sciences industries, as well as become the foundation for Precision Medicine regulatory and compliance efforts. HIVE is a distributed computing environment used for healthcare technology and biological research. MDEpiNet-HIVE is a technology that provides a secure healthcare biomedical data archival ecosystem. MDEpiNet-HIVE maintains a standardization and harmonization framework, high-performance analytics, and an integrator platform. In addition to the initial HIVE applications to next-generation sequencing, the current universe of HIVE projects covers tailor-made applications involving dimensionality analysis, federated and integrated data mapping, modeling and simulations that apply to basic research, biostatistics, epidemiology, clinical studies, post-market evaluation, manufacturing consistency, environmental metagenomics, outbreak detection, etc. About MDEpiNet MDEpiNet is a global Public-Private Partnership, established in 2010, that brings together leadership, expertise, and resources from health care professionals, industry, patient groups, payers, academia, and government to advance a national patient-centered medical device evaluation and surveillance system. The MDEpiNet Coordinating Center at Weill Cornell Medicine supports MDEpiNet operations under a cooperative agreement with the US Food and Drug Administration, Center for Devices and Radiological Health. MDEpiNet's mission is to develop and test novel methods, infrastructure, and partnerships for the creation of re-useable real-world data resources and support device evaluation by multiple stakeholders. In doing so, MDEpiNet collaborates with over 150 partnering organizations, including 120 registries from 45 countries, and has research chapters in the US, Europe, Asia, and Australia. About Softhread Softhread is an information technology company that uses Chios™ - a patent-pending blockchain and AI-enabled platform that preserves confidentiality and optimizes network security while enhancing operational efficiency. Through its decentralized system that empowers state-of-the-art interoperability, Softhread builds scalable enterprise solutions that are highly customizable, industry-agnostic, and optimize the ROI of data management.

Read More

HEALTH TECHNOLOGY

DeepIntent® introduces DeepIntent Outcomes

DeepIntent | April 07, 2021

DeepIntent, the leading healthcare marketing technology company built to influence patient health and business outcomes, today announced DeepIntent Outcomes, which uses real-world clinical evidence to significantly boost script lift attributed to digital advertising. DeepIntent Outcomes, which is built into its Healthcare Demand-Side Platform (DSP), allows advertisers to measure and automatically optimize live promotions based on script performance from pharmaceutical claims data that is updated regularly. DeepIntent Outcomes assists healthcare marketers in solving today's common barriers, such as data silos, the use of multiple channels, and delayed reporting. DeepIntent Outcomes enables marketers to use script performance to reduce waste, improve marketing mix in-flight and: Plan their strategies focused on insights into patients' and providers' in-market behaviors. Enable their media plans for all devices via a single platform; Monitor the effects of each campaign in real-time Optimize campaign efficiency regularly by automatically modifying creative, reach, frequency, publishers, pricing, and bidding strategy. DeepIntent Outcomes promotes the ability to measure the combined impact of patient and provider advertisement on script lift as one of the strategic use cases. DeepIntent Outcomes partnered with Publicis Health Media to coordinate and measure ad exposures to patients and caregivers with one of their leading pharmaceutical clients. Through this new platform, their client's script lift has increased by an average of 10-35 %. Through its collaboration with Komodo Health, DeepIntent Outcomes has access to the industry's most comprehensive, transparent, trusted, and verified healthcare data set, as well as the fastest pharmaceutical data refresh. DeepIntent's healthcare identification graph sees 75% of healthcare providers every day and 86% every month, with a 25% higher overall audience quality for patient campaigns. The combination of these two solutions provides previously unseen capabilities in the pharmaceutical market. DeepIntent was named Best-Buy Side Programmatic Platform by Digiday in 2020, beating out rivals such as Xandr and Verizon Media. About DeepIntent DeepIntent, founded by former Memorial Sloan Kettering data scientists, connects healthcare companies with patients and providers through all devices through proprietary data, media collaborations, and integrations. DeepIntent is seen to increase script lift while enhancing patients' quality of life from across the board, from campaign planning to audience targeting to measuring and maximizing. Its Healthcare Marketing Platform enables marketers at seven of the top ten pharmaceutical companies and major healthcare advertising agencies to have a direct impact on health and business outcomes.

Read More

HEALTH TECHNOLOGY

Integra Community Care Network Partners is Building the Future of Community Healthcare on the Innovaccer Health Cloud

Integra Community Care, Innovaccer | May 12, 2021

Integra Community Care Network, LLC, a leading Rhode Island-based Accountable Care Organization, has collaborated with Innovaccer Inc., a leading healthcare technology firm, to use the Innovaccer Health Cloud to scale their population health management platform to additional providers, healthcare professionals, and communities in New England. Integra will be able to connect all of the data systems to make medical records more usable and useful. Integra will use the Innovaccer Health Cloud to ingest, aggregate, and normalize healthcare data across systems and settings, resulting in unified patient records and actionable insights that enhance clinical and financial, and operational goals. Integra will gain access to the insights through the Innovaccer Health Cloud's customizable dashboards. With these dashboards, Integra will be able to track its performance on various metrics and refine its activities. Innovaccer's platform supports FHIR APIs and is compliant with the most recent FHIR v4.0.1 version, allowing Integra to share data across the network smoothly and achieve true interoperability. Integra will be able to spot care gaps and engage the network providers with real-time updates with the point-of-care alerts on the Innovaccer Health Cloud. The Innovaccer Health Cloud will also assist network providers in assigning the required care management pathways for patient populations and personalizing healthcare experiences for their patients through outreach and engagement strategies. About Integra Community Care Network, LLC Integra Community Care Network is the state of Rhode Island's largest accountable care organization, representing over 150,000 residents.Integra offers a collaborative team of hospitals, doctors, nurses, social workers, community health workers, and pharmacists who work together to strengthen the community's health and well-being. The Integra network has been recognized locally and nationally for providing high-quality, cost-effective care through teamwork, care coordination, and a focus on preventative health and wellness. Integra is made up of Care New England Health System providers and other healthcare professionals, as well as Rhode Island Primary Care Physicians Corporation, and South County Health. About Innovaccer Innovaccer Inc. is a leading healthcare technology company headquartered in San Francisco that is dedicated to improving healthcare as a whole. The Innovaccer Health Cloud unifies patient data across systems and settings, enabling healthcare organizations to develop scalable, modern applications that improve clinical, operational, and financial outcomes. Innovaccer's solutions have been deployed in over 1,000 care settings across the United States, allowing over 37,000 providers to improve care delivery and collaborate with payers and life sciences firms. Innovaccer has assisted organizations in integrating medical records for over 24 million people, resulting in over $600 million in savings..Innovaccer has been named a Best in KLAS vendor in population health management for 2021, as well as the No. 1 customer-rated vendor by Black Book.

Read More